info
Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
PhD Position in Vascular Biology at Uppsala University
0 views
Skip to first unread message
Ema Shollenberger
Mar 13, 2019, 9:11:23 AM3/13/19
to emap...@gmail.com
The Department of Immunology, Genetics and Pathology at Uppsala University (www.igp.uu.se) has a broad research profile with strong research groups focused on cancer, autoimmune and genetic diseases. A fundamental idea at the department is to stimulate translational research and thereby closer interactions between medical research and health care. Research is presently conducted in the following areas: medical and clinical genetics, clinical immunology, pathology, neuro-oncology, vascular biology, radiation science and molecular tools. Department activities are also integrated with the units for Oncology, Clinical Genetics, Clinical Immunology, Clinical Pathology, and Hospital Physics at Akademiska sjukhuset, Uppsala. The department has teaching assignments in several education programmes, including Master Programmes, at the Faculty of Medicine, and in a number of educations at the Disciplinary Domain of Science and Technology. The department has a yearly turnover of around SEK 400 million, out of which more than half is made up of external funding. The staff amounts to approximately 340 employees, out of which 100 are PhD-students, and there are in total more than 600 affiliated people.
Vascular biology group:
The student will be placed in the Vascular biology research group headed by Lena Claesson-Welsh (http://www.igp.uu.se/forskning/vaskularbiologi/lena-claesson-welsh/) who will serve as the main supervisor. Mark Richards and Anna Dimberg will serve as co-supervisors. Our research group studies blood and lymphatic vessel biology in tissue culture, mouse and man. We ask how vessel formation and function are regulated in normal development and in pathological processes, such as cancer and retinopathy. We are particularly interested in leakage from blood and lymphatic vessels, how leakage is regulated and how it contributes to disease progression. This knowledge will be applied to the development of new therapeutics.
Blood vessels become established during development and expand during adult life; for example as a consequence of exercise, during the menstrual cycle and in wound healing. A number of diseases such as cancer, chronic inflammation and eye diseases are characterized by excessive blood vessel formation, leading to leaky and dysfunctional vessels. This in turn creates tissue edema and inflammation. To limit vessel leakage in pathological processes is therefore an important clinical need. The project is based on new methodology for the microscopic analysis of leaky vessels in tissues such as the skin and the eye. Substances are injected into the tissue to induce or modulate leakage, which is imaged 'live' by multiphoton microscopy. Leakage is quantified by image analysis and leakage mechanisms examined by the use of genetically modified mouse models and correlative confocal microscopy. Mechanistic findings will be correlated to the progression of cancer or eye disease (retinopathy or choroidal neovascularization). Recombinant mouse models will be generated through CRISPR/Cas9 technology.
Applications are accepted from highly motivated candidates with a master degree in Biomedicine, (Molecular) Medicine, Molecular (Cell) Biology or similar. Written and oral proficiency in English is a prerequisite, as is basic knowledge of, and skills in cell biology. A successful candidate should be a highly motivated, organized, reliable team player that can also work independently and is comfortable working with mice. Prior experience in immunocytochemistry, fluorescence microscopy and excel-based analysis is essential. Knowledge of bioinformatics, statistical analysis, programming and image-based analyses are a bonus.
If available, a Master thesis (completed or in draft form) and letters of recommendation can also be included.
Rules governing Ph.D. candidates are set out in the Higher Education Ordinance Chapter 5, 1-7 and in Uppsala university’s rules and guidelines
http://regler.uu.se/?languageId=1
Uppsala University strives to be an inclusive workplace that promotes equal opportunities and attracts qualified candidates who can contribute to the Universitys excellence and diversity. We welcome applications from all sections of the community and from people of all backgrounds.
For instructions on how to apply, please refer to: http://bit.ly/2O0sCb7
Vascular biology group:
The student will be placed in the Vascular biology research group headed by Lena Claesson-Welsh (http://www.igp.uu.se/forskning/vaskularbiologi/lena-claesson-welsh/) who will serve as the main supervisor. Mark Richards and Anna Dimberg will serve as co-supervisors. Our research group studies blood and lymphatic vessel biology in tissue culture, mouse and man. We ask how vessel formation and function are regulated in normal development and in pathological processes, such as cancer and retinopathy. We are particularly interested in leakage from blood and lymphatic vessels, how leakage is regulated and how it contributes to disease progression. This knowledge will be applied to the development of new therapeutics.
Blood vessels become established during development and expand during adult life; for example as a consequence of exercise, during the menstrual cycle and in wound healing. A number of diseases such as cancer, chronic inflammation and eye diseases are characterized by excessive blood vessel formation, leading to leaky and dysfunctional vessels. This in turn creates tissue edema and inflammation. To limit vessel leakage in pathological processes is therefore an important clinical need. The project is based on new methodology for the microscopic analysis of leaky vessels in tissues such as the skin and the eye. Substances are injected into the tissue to induce or modulate leakage, which is imaged 'live' by multiphoton microscopy. Leakage is quantified by image analysis and leakage mechanisms examined by the use of genetically modified mouse models and correlative confocal microscopy. Mechanistic findings will be correlated to the progression of cancer or eye disease (retinopathy or choroidal neovascularization). Recombinant mouse models will be generated through CRISPR/Cas9 technology.
Applications are accepted from highly motivated candidates with a master degree in Biomedicine, (Molecular) Medicine, Molecular (Cell) Biology or similar. Written and oral proficiency in English is a prerequisite, as is basic knowledge of, and skills in cell biology. A successful candidate should be a highly motivated, organized, reliable team player that can also work independently and is comfortable working with mice. Prior experience in immunocytochemistry, fluorescence microscopy and excel-based analysis is essential. Knowledge of bioinformatics, statistical analysis, programming and image-based analyses are a bonus.
If available, a Master thesis (completed or in draft form) and letters of recommendation can also be included.
Rules governing Ph.D. candidates are set out in the Higher Education Ordinance Chapter 5, 1-7 and in Uppsala university’s rules and guidelines
http://regler.uu.se/?languageId=1
Uppsala University strives to be an inclusive workplace that promotes equal opportunities and attracts qualified candidates who can contribute to the Universitys excellence and diversity. We welcome applications from all sections of the community and from people of all backgrounds.
For instructions on how to apply, please refer to: http://bit.ly/2O0sCb7
0 new messages